Hidenobu Kojima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hidenobu Kojima has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Satoshi Ogiso
Department of Surgery, Graduate School of Medicine Kyoto University Kyoto Japan
7 shared publications - Etsuro Hatano
Department of Surgery, Graduate School of Medicine Kyoto University Kyoto Japan
6 shared publications - Shoichi Kageyama
Department of Surgery, Graduate School of Medicine Kyoto University Kyoto Japan
6 shared publications - Takamichi Ishii
Department of Surgery, Graduate School of Medicine Kyoto University Kyoto Japan
6 shared publications - Yoichiro Uchida
Department of Surgery, Graduate School of Medicine Kyoto University Kyoto Japan
5 shared publications - Kazuyuki Nagai
Department of Surgery, Graduate School of Medicine Kyoto University Kyoto Japan
4 shared publications
Latest Publications
- Open Access
- 2 November 2026
- Published byĀ WileyĀ inĀ Journal of Hepato-Biliary-Pancreatic Sciences
PancreasāIntestine Composite Transplantation for Simultaneous Loss of Pancreatic and Intestinal Function (With Video)
Pancreasāintestine composite transplantation (PITx) is a therapeutic option for patients with irreversible loss of both pancreatic and intestinal function. We report a case of PITx in a 16āyearāold male who developed fulminant Type 1 diabetes mellitus complicated by nonāocclusive mesenteric ischemia, resulting in extensive intestinal necrosis. Despite intensive surgical and critical care management, the patient ultimately required total small intestinal resection and total pancreatectomy. After recovery from sepsis and multiorgan dysfunction, the patient's general condition stabilized, and PITx was considered an appropriate therapeutic option. The composite graft consisted of the pancreas, duodenum, small intestine, and right colon. Arterial inflow was reconstructed using a single Carrel patch incorporating the celiac axis and superior mesenteric artery, and venous outflow was established by portal vein anastomosis. Postoperatively, pancreatic endocrine function was restored, allowing stable glycemic control without exogenous insulin, and intestinal graft function enabled the gradual advancement of enteral and oral nutrition. This report highlights the key technical considerations and anatomical principles of PITx and demonstrates that tailored composite graft transplantation can restore both pancreatic and intestinal function while preserving unaffected abdominal organs in highly selected patients with combined pancreatic and intestinal failure.
- 2 November 2026
- Published byĀ WileyĀ inĀ Journal of Hepato-Biliary-Pancreatic Sciences
Open AccessPancreasāIntestine Composite Transplantation for Simultaneous Loss of Pancreatic and Intestinal Function (With Video)
Pancreasāintestine composite transplantation (PITx) is a therapeutic option for patients with irreversible loss of both pancreatic and intestinal function. We report a case of PITx in a 16āyearāold male who developed fulminant Type 1 diabetes mellitus complicated by nonāocclusive mesenteric ischemia, resulting in extensive intestinal necrosis. Despite intensive surgical and critical care management, the patient ultimately required total small intestinal resection and total pancreatectomy. After recovery from sepsis and multiorgan dysfunction, the patient's general condition stabilized, and PITx was considered an appropriate therapeutic option. The composite graft consisted of the pancreas, duodenum, small intestine, and right colon. Arterial inflow was reconstructed using a single Carrel patch incorporating the celiac axis and superior mesenteric artery, and venous outflow was established by portal vein anastomosis. Postoperatively, pancreatic endocrine function was restored, allowing stable glycemic control without exogenous insulin, and intestinal graft function enabled the gradual advancement of enteral and oral nutrition. This report highlights the key technical considerations and anatomical principles of PITx and demonstrates that tailored composite graft transplantation can restore both pancreatic and intestinal function while preserving unaffected abdominal organs in highly selected patients with combined pancreatic and intestinal failure.
- Open Access
- 8 October 2026
- Published byĀ WileyĀ inĀ Journal of Hepato-Biliary-Pancreatic Sciences
Notation System for Liver Transplant Recipients: Key Information in Transplant Procedure
Liver transplantation (LT) is a standard therapy for patients with endāstage liver disease and certain hepatic malignancies. The LT procedure has diversified due to donor shortages and advances in immunosuppressive treatments and surgical techniques. Donor organ shortages have promoted the use of living donor liver transplantation and āmarginalā livers, including donation after circulatory death. ABOāincompatible liver transplants now show outcomes comparable with ABOācompatible transplants when a desensitization protocol is used. Hepaticojejunostomy, rather than ductātoāduct anastomosis, is performed in select cases with an unsuitable common bile duct or in patients with primary sclerosing cholangitis. These procedural differences affect followāup management in LT recipients. Given the increasing diversity of transplant surgeries and the longāterm prognosis after LT, it is essential for healthcare professionals and transplant societies to be informed about the specific procedures performed in LT recipients. We aimed to propose a notation system for LT recipients that documents key procedural information, including the number of transplantations, donor type with donor/recipient blood types in ABOāincompatible transplantation, graft type, the number of reconstructed vessels, and the number and type of biliary reconstruction. The use of a common notation system for transplant procedures can facilitate patient management, communication, and accurate understanding of transplant procedures.
- 8 October 2026
- Published byĀ WileyĀ inĀ Journal of Hepato-Biliary-Pancreatic Sciences
Open AccessNotation System for Liver Transplant Recipients: Key Information in Transplant Procedure
Liver transplantation (LT) is a standard therapy for patients with endāstage liver disease and certain hepatic malignancies. The LT procedure has diversified due to donor shortages and advances in immunosuppressive treatments and surgical techniques. Donor organ shortages have promoted the use of living donor liver transplantation and āmarginalā livers, including donation after circulatory death. ABOāincompatible liver transplants now show outcomes comparable with ABOācompatible transplants when a desensitization protocol is used. Hepaticojejunostomy, rather than ductātoāduct anastomosis, is performed in select cases with an unsuitable common bile duct or in patients with primary sclerosing cholangitis. These procedural differences affect followāup management in LT recipients. Given the increasing diversity of transplant surgeries and the longāterm prognosis after LT, it is essential for healthcare professionals and transplant societies to be informed about the specific procedures performed in LT recipients. We aimed to propose a notation system for LT recipients that documents key procedural information, including the number of transplantations, donor type with donor/recipient blood types in ABOāincompatible transplantation, graft type, the number of reconstructed vessels, and the number and type of biliary reconstruction. The use of a common notation system for transplant procedures can facilitate patient management, communication, and accurate understanding of transplant procedures.
- 25 February 2026
- Published byĀ WileyĀ inĀ Hepatology Research
- Vol.Ā 56 Ā (6) , 933-943
Regeneration of the Human Intrahepatic Nervous System in Living Donor Liver Transplantation Recipients
Aim: Nerve fibers in the liver help to regulate blood flow and metabolism. They spread from the porta hepatis along the Glissonean sheath (GS) to the hepatocytes and the surrounding areas. In liver transplants, these nerves are completely resected, but their regeneration is not well known. This study examined how and when these nerves regenerate following living donor liver transplantation (LDLT). Methods: The study included 7 patients who underwent LDLT, with followāup periods ranging from 5 to 27 years. Six patients underwent followāup biopsies, and 1 patient underwent wholeāliver reātransplantation. A biopsy specimen obtained during transplantation was used as the control. Nerve regeneration was assessed using synaptophysin immunohistological staining to detect nerve fibers. Results: In 6 cases, nerve fibers disappeared soon after the transplant and were not observed for months or years. In three cases with followāup periods exceeding 15 years, nerve fibers were observed around the GS only after more than 15 years had elapsed. In the reātransplanted liver, thick nerve fibers grew around the large GS, but thin fibers did not appear around the smaller GS or within liver lobules. Conclusions: Nerve fibers from donor liver diminished immediately after LDLT. They grew mainly around the medium to large GS, with little or no growth within the lobules.
- 25 February 2026
- Published byĀ WileyĀ inĀ Hepatology Research
- Vol.Ā 56 Ā (6) , 933-943
Regeneration of the Human Intrahepatic Nervous System in Living Donor Liver Transplantation Recipients
Aim: Nerve fibers in the liver help to regulate blood flow and metabolism. They spread from the porta hepatis along the Glissonean sheath (GS) to the hepatocytes and the surrounding areas. In liver transplants, these nerves are completely resected, but their regeneration is not well known. This study examined how and when these nerves regenerate following living donor liver transplantation (LDLT). Methods: The study included 7 patients who underwent LDLT, with followāup periods ranging from 5 to 27 years. Six patients underwent followāup biopsies, and 1 patient underwent wholeāliver reātransplantation. A biopsy specimen obtained during transplantation was used as the control. Nerve regeneration was assessed using synaptophysin immunohistological staining to detect nerve fibers. Results: In 6 cases, nerve fibers disappeared soon after the transplant and were not observed for months or years. In three cases with followāup periods exceeding 15 years, nerve fibers were observed around the GS only after more than 15 years had elapsed. In the reātransplanted liver, thick nerve fibers grew around the large GS, but thin fibers did not appear around the smaller GS or within liver lobules. Conclusions: Nerve fibers from donor liver diminished immediately after LDLT. They grew mainly around the medium to large GS, with little or no growth within the lobules.
- 14 October 2025
- Published byĀ MyJove CorporationĀ inĀ Journal of Visualized Experiments
- No.Ā 224,p. e69234
Suture Techniques for Vascular Reconstruction in Mouse Orthotopic Liver Transplantation
Translational research using animal models is essential for addressing the clinical issues in organ transplantations. Although mouse orthotopic liver transplantation (LT) is a useful tool for investigating the mechanisms of liver regeneration, ischemia-reperfusion injury, and immune responses following LT, technical challenges in this procedure restrict its feasibility. The key aspects for successful mouse orthotopic LT are vascular reconstruction in recipients, including the suprahepatic inferior vena cava (SHIVC), portal vein (PV), and infrahepatic inferior vena cava (IHIVC). In addition to the technical difficulties in reconstructing these vessels, the time limitation of the anhepatic phase to within 20 min makes this procedure more challenging. Although a cuff technique can be used for PV reconstruction, a safe and quick suture technique is required to reconstruct the SHIVC during the anhepatic phase. For IHIVC reconstruction, while both cuff and suture techniques are applicable, the suture technique leads to a shorter operation time in donor surgery and back-table preparation and can maintain a larger vascular lumen than the cuff technique. We herein provide guidelines for SHIVC and IHIVC reconstruction using a suture technique to facilitate mouse orthotopic LT.
- 14 October 2025
- Published byĀ MyJove CorporationĀ inĀ Journal of Visualized Experiments
- No.Ā 224,p. e69234
Suture Techniques for Vascular Reconstruction in Mouse Orthotopic Liver Transplantation
Translational research using animal models is essential for addressing the clinical issues in organ transplantations. Although mouse orthotopic liver transplantation (LT) is a useful tool for investigating the mechanisms of liver regeneration, ischemia-reperfusion injury, and immune responses following LT, technical challenges in this procedure restrict its feasibility. The key aspects for successful mouse orthotopic LT are vascular reconstruction in recipients, including the suprahepatic inferior vena cava (SHIVC), portal vein (PV), and infrahepatic inferior vena cava (IHIVC). In addition to the technical difficulties in reconstructing these vessels, the time limitation of the anhepatic phase to within 20 min makes this procedure more challenging. Although a cuff technique can be used for PV reconstruction, a safe and quick suture technique is required to reconstruct the SHIVC during the anhepatic phase. For IHIVC reconstruction, while both cuff and suture techniques are applicable, the suture technique leads to a shorter operation time in donor surgery and back-table preparation and can maintain a larger vascular lumen than the cuff technique. We herein provide guidelines for SHIVC and IHIVC reconstruction using a suture technique to facilitate mouse orthotopic LT.
- 14 October 2025
- Published byĀ MyJove Corporation
- No.Ā 224,p. e69234
JoVE Video Dataset
Translational research using animal models is essential for addressing the clinical issues in organ transplantations. Although mouse orthotopic liver transplantation (LT) is a useful tool for investigating the mechanisms of liver regeneration, ischemia-reperfusion injury, and immune responses following LT, technical challenges in this procedure restrict its feasibility. The key aspects for successful mouse orthotopic LT are vascular reconstruction in recipients, including the suprahepatic inferior vena cava (SHIVC), portal vein (PV), and infrahepatic inferior vena cava (IHIVC). In addition to the technical difficulties in reconstructing these vessels, the time limitation of the anhepatic phase to within 20 min makes this procedure more challenging. Although a cuff technique can be used for PV reconstruction, a safe and quick suture technique is required to reconstruct the SHIVC during the anhepatic phase. For IHIVC reconstruction, while both cuff and suture techniques are applicable, the suture technique leads to a shorter operation time in donor surgery and back-table preparation and can maintain a larger vascular lumen than the cuff technique. We herein provide guidelines for SHIVC and IHIVC reconstruction using a suture technique to facilitate mouse orthotopic LT.
- 14 October 2025
- Published byĀ MyJove Corporation
- No.Ā 224,p. e69234
JoVE Video Dataset
Translational research using animal models is essential for addressing the clinical issues in organ transplantations. Although mouse orthotopic liver transplantation (LT) is a useful tool for investigating the mechanisms of liver regeneration, ischemia-reperfusion injury, and immune responses following LT, technical challenges in this procedure restrict its feasibility. The key aspects for successful mouse orthotopic LT are vascular reconstruction in recipients, including the suprahepatic inferior vena cava (SHIVC), portal vein (PV), and infrahepatic inferior vena cava (IHIVC). In addition to the technical difficulties in reconstructing these vessels, the time limitation of the anhepatic phase to within 20 min makes this procedure more challenging. Although a cuff technique can be used for PV reconstruction, a safe and quick suture technique is required to reconstruct the SHIVC during the anhepatic phase. For IHIVC reconstruction, while both cuff and suture techniques are applicable, the suture technique leads to a shorter operation time in donor surgery and back-table preparation and can maintain a larger vascular lumen than the cuff technique. We herein provide guidelines for SHIVC and IHIVC reconstruction using a suture technique to facilitate mouse orthotopic LT.
- 27 September 2025
- Published byĀ ElsevierĀ inĀ American Journal of Transplantation
- Vol.Ā 26 Ā (1) , 204-205
Reply to: Do T/B lymphocytes mask the protective effects of group 1 innate lymphoid cells against liver graft ischemia-reperfusion injury?
- 27 September 2025
- Published byĀ ElsevierĀ inĀ American Journal of Transplantation
- Vol.Ā 26 Ā (1) , 204-205
Reply to: Do T/B lymphocytes mask the protective effects of group 1 innate lymphoid cells against liver graft ischemia-reperfusion injury?
- Open Access
- 8 March 2025
- Published byĀ ElsevierĀ inĀ American Journal of Transplantation
- Vol.Ā 25 Ā (6) , 1168-1179
Recipient toll-like receptor 4 determines the outcome of ischemia-reperfusion injury in steatotic liver transplantation in mice
- 8 March 2025
- Published byĀ ElsevierĀ inĀ American Journal of Transplantation
- Vol.Ā 25 Ā (6) , 1168-1179
Open AccessRecipient toll-like receptor 4 determines the outcome of ischemia-reperfusion injury in steatotic liver transplantation in mice
- Open Access
- 28 December 2024
- Published byĀ ElsevierĀ inĀ American Journal of Transplantation
- Vol.Ā 25 Ā (5) , 969-984
Group 1 innate lymphoid cells protect liver transplants from ischemia-reperfusion injury via an interferon gammaāmediated pathway
- 28 December 2024
- Published byĀ ElsevierĀ inĀ American Journal of Transplantation
- Vol.Ā 25 Ā (5) , 969-984
Open AccessGroup 1 innate lymphoid cells protect liver transplants from ischemia-reperfusion injury via an interferon gammaāmediated pathway
- Open Access
- 9 August 2023
- Published byĀ ElsevierĀ inĀ American Journal of Transplantation
- Vol.Ā 23 Ā (12) , 1858-1871
Disulfide-HMGB1 signals through TLR4 and TLR9 to induce inflammatory macrophages capable of innate-adaptive crosstalk in human liver transplantation
- 9 August 2023
- Published byĀ ElsevierĀ inĀ American Journal of Transplantation
- Vol.Ā 23 Ā (12) , 1858-1871
Open AccessDisulfide-HMGB1 signals through TLR4 and TLR9 to induce inflammatory macrophages capable of innate-adaptive crosstalk in human liver transplantation
- Open Access
- 23 March 2020
- Published byĀ American Society for Clinical InvestigationĀ inĀ Journal of Clinical Investigation
- Vol.Ā 130 Ā (5) , 2689-2704
Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury
Although CEACAM1 (CC1) glycoprotein resides at the interface of immune liver injury and metabolic homeostasis, its role in orthotopic liver transplantation (OLT) remains elusive. We aimed to determine whether/how CEACAM1 signaling may affect hepatic ischemia-reperfusion injury (IRI) and OLT outcomes. In the mouse, donor liver CC1 null mutation augmented IRI-OLT (CC1-KOāWT) by enhancing ROS expression and HMGB1 translocation during cold storage, data supported by in vitro studies where hepatic flush from CC1-deficient livers enhanced macrophage activation in bone marrowāderived macrophage cultures. Although hepatic CC1 deficiency augmented cold stressātriggered ASK1/p-p38 upregulation, adjunctive ASK1 inhibition alleviated IRI and improved OLT survival by suppressing p-p38 upregulation, ROS induction, and HMGB1 translocation (CC1-KOāWT), whereas ASK1 silencing (siRNA) promoted cytoprotection in cold-stressed and damage-prone CC1-deficient hepatocyte cultures. Consistent with mouse data, CEACAM1 expression in 60 human donor liver biopsies correlated negatively with activation of the ASK1/p-p38 axis, whereas low CC1 levels associated with increased ROS and HMGB1 translocation, enhanced innate and adaptive immune responses, and inferior early OLT function. Notably, reduced donor liver CEACAM1 expression was identified as one of the independent predictors for early allograft dysfunction (EAD) in human OLT patients. Thus, as a checkpoint regulator of IR stress and sterile inflammation, CEACAM1 may be considered as a denominator of donor hepatic tissue quality, and a target for therapeutic modulation in OLT recipients.
- 23 March 2020
- Published byĀ American Society for Clinical InvestigationĀ inĀ Journal of Clinical Investigation
- Vol.Ā 130 Ā (5) , 2689-2704
Open AccessHepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury
Although CEACAM1 (CC1) glycoprotein resides at the interface of immune liver injury and metabolic homeostasis, its role in orthotopic liver transplantation (OLT) remains elusive. We aimed to determine whether/how CEACAM1 signaling may affect hepatic ischemia-reperfusion injury (IRI) and OLT outcomes. In the mouse, donor liver CC1 null mutation augmented IRI-OLT (CC1-KOāWT) by enhancing ROS expression and HMGB1 translocation during cold storage, data supported by in vitro studies where hepatic flush from CC1-deficient livers enhanced macrophage activation in bone marrowāderived macrophage cultures. Although hepatic CC1 deficiency augmented cold stressātriggered ASK1/p-p38 upregulation, adjunctive ASK1 inhibition alleviated IRI and improved OLT survival by suppressing p-p38 upregulation, ROS induction, and HMGB1 translocation (CC1-KOāWT), whereas ASK1 silencing (siRNA) promoted cytoprotection in cold-stressed and damage-prone CC1-deficient hepatocyte cultures. Consistent with mouse data, CEACAM1 expression in 60 human donor liver biopsies correlated negatively with activation of the ASK1/p-p38 axis, whereas low CC1 levels associated with increased ROS and HMGB1 translocation, enhanced innate and adaptive immune responses, and inferior early OLT function. Notably, reduced donor liver CEACAM1 expression was identified as one of the independent predictors for early allograft dysfunction (EAD) in human OLT patients. Thus, as a checkpoint regulator of IR stress and sterile inflammation, CEACAM1 may be considered as a denominator of donor hepatic tissue quality, and a target for therapeutic modulation in OLT recipients.